Detalhe da pesquisa
1.
Different prognostic values of KRAS exon 2 submutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of seven trials.
Ann Oncol
; 34(11): 1025-1034, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37619846
2.
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study.
Ann Oncol
; 31(7): 921-929, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294529
3.
Overcoming barriers in biomarker testing. Letter to the Editor regarding: "ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe", by A. Bayle et al.
Ann Oncol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723866
4.
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.
Ann Oncol
; 30(4): 510-519, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721924
5.
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
Ann Surg Oncol
; 26(11): 3561-3567, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209667
6.
RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Ann Oncol
; 29(5): 1211-1219, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438522
7.
Predictive Modeling of Tacrolimus Dose Requirement Based on High-Throughput Genetic Screening.
Am J Transplant
; 17(4): 1008-1019, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27597269
8.
CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
Ann Oncol
; 28(5): 1032-1035, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328000
9.
Molecular classification of pulmonary sarcomatoid carcinomas suggests new therapeutic opportunities.
Ann Oncol
; 28(7): 1597-1604, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419182
10.
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.
Ann Oncol
; 28(5): 958-968, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453690
11.
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Ann Oncol
; 28(4): 824-830, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28031175
12.
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.
Ann Oncol
; 27(8): 1386-422, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27380959
13.
Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers.
Br J Cancer
; 113(4): 680-5, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26171935
14.
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 31(10): 1291-1305, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702383
15.
Corrigendum to 'Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study': Annals of Oncology 2020; Volume 31: 921-929.
Ann Oncol
; 31(9): 1276, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653357
16.
Frequent intragenic rearrangements of DPYD in colorectal tumours.
Pharmacogenomics J
; 15(3): 211-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25348620
17.
Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France).
J Eur Acad Dermatol Venereol
; 29(12): 2436-43, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377147
18.
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.
Br J Cancer
; 110(5): 1148-54, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407191
19.
Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study.
Br J Cancer
; 110(11): 2728-37, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800948
20.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 25(12): 2378-2385, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25294886